These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats. Ginovart N, Wilson AA, Houle S, Kapur S. Biol Psychiatry; 2004 Jun 15; 55(12):1188-94. PubMed ID: 15184038 [Abstract] [Full Text] [Related]
4. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride. Jensen SB, Olsen AK, Pedersen K, Cumming P. Synapse; 2006 Jun 01; 59(7):427-34. PubMed ID: 16485265 [Abstract] [Full Text] [Related]
5. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride. Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M. Synapse; 2004 Jun 01; 52(3):188-208. PubMed ID: 15065219 [Abstract] [Full Text] [Related]
6. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography. van Berckel BN, Kegeles LS, Waterhouse R, Guo N, Hwang DR, Huang Y, Narendran R, Van Heertum R, Laruelle M. Neuropsychopharmacology; 2006 May 01; 31(5):967-77. PubMed ID: 16177807 [Abstract] [Full Text] [Related]
7. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride. Seneca N, Finnema SJ, Farde L, Gulyás B, Wikström HV, Halldin C, Innis RB. Synapse; 2006 Apr 01; 59(5):260-9. PubMed ID: 16416444 [Abstract] [Full Text] [Related]
9. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system. Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N. Synapse; 2006 Aug 01; 60(2):172-83. PubMed ID: 16715499 [Abstract] [Full Text] [Related]
10. Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique. Sasaki T, Ishiwata K, Murata T, Senda M. Synapse; 2002 Apr 01; 44(1):42-50. PubMed ID: 11842445 [Abstract] [Full Text] [Related]
11. Nicotine-induced dopamine release in primates measured with [11C]raclopride PET. Marenco S, Carson RE, Berman KF, Herscovitch P, Weinberger DR. Neuropsychopharmacology; 2004 Feb 01; 29(2):259-68. PubMed ID: 14666115 [Abstract] [Full Text] [Related]
13. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M, Gunn R, Young SN, Benkelfat C. Neuropsychopharmacology; 2004 Feb 01; 29(2):427-32. PubMed ID: 14583741 [Abstract] [Full Text] [Related]
14. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain. Kobayashi K, Inoue O, Watanabe Y, Onoe H, Långström B. J Neural Transm Gen Sect; 1995 Feb 01; 100(2):147-51. PubMed ID: 8962684 [Abstract] [Full Text] [Related]
19. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges. Seeman P, Tallerico T, Ko F, Tenn C, Kapur S. Synapse; 2002 Dec 15; 46(4):235-9. PubMed ID: 12373738 [Abstract] [Full Text] [Related]